Medical Countermeasures New Mutation and DNA Repeats Behind Ceftazidime Resistance in Melioidosis BacteriumGlobal Biodefense StaffSeptember 5, 2025
Medical Countermeasures Appili Therapeutics Reports Strong Preclinical Protection from ATI-1701 Tularemia VaccineGlobal Biodefense StaffAugust 11, 2025
Medical Countermeasures Pan-Coronavirus Drug Discovery Gets a Boost from Global AI Blind ChallengeGlobal Biodefense StaffJuly 28, 2025
Finding the Golden Window for Collecting COVID-19 Survivor Antibodies Biodetection October 19, 2020 …
Until a Coronavirus Vaccine is Ready, Pneumonia Vaccines May Reduce Deaths from COVID-19 Medical Countermeasures October 15, 2020 …
SARS, MERS, COVID-19: Repurposing Drugs for a Pan-Coronavirus Treatment Medical Countermeasures October 15, 2020 …
U.S. Invests in Pandemic Vaccine Manufacturing Capacity with $31M Contract to Cytiva Industry News October 15, 2020 …
Stopping Lethal Lung Damage from Influenza: MG53 Protein Shows Promise in Animal Models Medical Countermeasures October 13, 2020 …
High Dose Favipiravir Countered SARS-CoV-2 in Hamsters, Hydroxychloroquine Ineffective Medical Countermeasures October 10, 2020 …
Pipeline COVID-19 Vaccines Not Affected by ‘G-Strain’ Mutation Medical Countermeasures October 8, 2020 …
Renowned Tick Immunobiologist to Develop Lyme Disease Vaccine Under New $3.5M Federal Grant Contracts + Grants October 7, 2020 …
The Challenges of Vaccine Cold-Chain Distribution Must Be Met to End the Pandemic Medical Countermeasures October 5, 2020 …
Vaxxas Awarded $22M to Advance Needle-Free Vaccine Technology for Pandemic Response Industry News October 5, 2020 …
Operation Warp Speed’s Big Vaccine Contracts Could Stay Secret Medical Countermeasures September 29, 2020 …
Basilea Awarded Additional Funding from U.S. Medical Countermeasure Program for Ceftobiprole Development Antimicrobial Resistance September 28, 2020 …
Remdesivir: Second Mechanism of Action Against SARS-CoV-2 Revealed in New Study Medical Countermeasures September 23, 2020 …
NIH Expands COVID-19 Convalescent Plasma Clinical Trials Medical Countermeasures September 22, 2020 …
HHS Pushes Out COVID-19 Mass Vaccination Playbook, Distribution Strategy Medical Countermeasures September 16, 2020 …
